Successful response to rituximab in a patient with pure red cell aplasia complicating chronic lymphocytic leukaemia.
Montserrat
M
Batlle
Josep-Maria
JM
Ribera
Albert
A
Oriol
Esther
E
Plensa
Fuensanta
F
Millá
Evarist
E
Feliu
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D008297:Male; D008875:Middle Aged; D012010:Red-Cell Aplasia, Pure / Q000150:complications / Q000188:drug therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab